在患有慢性冠状动脉全封闭症的患者中,完整或不完整的皮肤再血管化
Luis Carlos Maestre-Luque1,2, Rafael Gonzalez-Manzanares1,2,3, Javier Suárez de Lezo1,2,3
1Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain.
Frontiers in cardiovascular medicine
|August 7, 2024
概括
针对慢性全闭症 (CTO) 进行完整的皮肤穿透再血管化 (CR-CTO),可显著减少主要心血管不良事件 (MACE). 这项研究发现,CR-CTO在中期降低了MACE风险,突出了其在治疗复杂冠状动脉疾病方面的好处.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 血管医学 血管医学
背景情况:
- 对于慢性全闭症 (CTO) 的穿皮冠状动脉干预 (PCI) 仍然存在争议.
- 评估完全重血管化的临床结果的影响对于患者管理至关重要.
研究的目的:
- 评估CTO完全重血管化的对主要心血管不良事件 (MACE) 的影响.
- 为了比较CTO (CR-CTO) 完全重血管化和不完全重血管化 (ICR-CTO) 之间的结果.
主要方法:
- 对359名CTO患者进行了入侵性冠状动脉血管造影的回顾性观察研究.
- 患者被分为CR-CTO和ICR-CTO组.
- 主要终点是MACE的复合,包括死亡,心肌梗塞,中风或无计划的再血管化,在中期随访期间进行评估.
主要成果:
- 在46.5%的患者中,实现了完整的血管恢复.
- 在平均42个月的随访后,MACE发生在CR-CTO组的23.4%,而ICR-CTO组的39.1% (HR0.50,p < 0.001).
- 经过反向概率加权 (调整HR为0.61,p=0.018) 后,这种关联仍然显著,主要是由于减少了全因死亡率.
结论:
- 完整的CTO再血管化与MACE的风险明显降低有关.
- 这些发现支持在CTO患者中实现完全重血管化的好处.
- 在患有复杂冠状动脉疾病的患者中,CR-CTO可能会改善中期生存率.
相关概念视频
01:28Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...